超越铁素-1:对铁灭抑制剂的全面审查
Camilla Scarpellini1, Greta Klejborowska1, Caroline Lanthier1
1Laboratory of Medicinal Chemistry, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, 2610 Antwerp, Belgium.
Trends in pharmacological sciences
|September 28, 2023
概括
作为细胞死亡途径的铁亡,可以通过捕捉基因的抗氧化剂 (RTAs) 来阻止. 本综述分析了RTA在ferroptosis相关疾病中的潜在治疗应用.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 铁亡是一种依赖于铁的调节细胞死亡,其特征是膜脂质过氧化.
- 铁素1是一种合成的基因捕捉抗氧化剂 (RTA),是关键的抑制剂和参考化合物.
- 铁亡与各种疾病有关,这表明其抑制剂具有治疗潜力.
研究的目的:
- 为了提供有关铁灭抑制剂的全面概述.
- 专注于内源性和合成的激素捕获抗氧化剂 (RTA).
- 分析RTAs的化学,药理动力学和体内特性.
主要方法:
- 关于铁灭抑制剂的文献综述.
- 对内源性和合成基因捕捉抗氧化剂 (RTA) 的分析.
- 在体内使用的化学,药理动力学和药理学性质的评估.
主要成果:
- 捕捉激素的抗氧化剂 (RTAs) 在阻断铁灭方面优越.
- 详细分析了不同类型的铁灭抑制剂,特别是RTAs.
- 对于各种RTAs,与体内应用相关的特性进行了讨论.
结论:
- 脂友激素捕获抗氧化剂 (RTA) 仍然是最有效的铁灭抑制剂.
- 了解RTA的特性对于开发治疗策略来治疗与铁亡相关的疾病至关重要.
- 本综述为研究人员和药物开发人员提供铁灭抑制剂指南.
相关概念视频
Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Phosphoinositides and PIPs
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Necrosis
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...


